Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Change In Japan’s OTC Laws Bodes Changes In Buying Habits

This article was originally published in PharmAsia News

Executive Summary

A major change in Japan's laws governing the sale of over-the-counter drugs is expected to lead to a major change in consumer buying habits when it takes effect next April. As of that month, supermarkets and other large retailers are to be allowed to sell OTC drugs, currently confined to pharmacies. A price battle between the two groups is expected to result from relaxation of the pharmaceutical affairs law, placing pressure on drugstores that have seen rapid growth recently, but now face a need to change business models. The law change would remove the current requirement that limits OTC drug sales to pharmacists, allowing regular sales staff to sell the drugs after a year of drug-selling experience and a "registered drug seller" license. (Click here for more - a subscription may be required

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts